Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.27 USD | +0.04% | -1.00% | -3.79% |
Mar. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Mar. 18 | BTIG Upgrades Globus Medical to Buy From Neutral, Price Target is $60 | MT |
Financials (USD)
Sales 2024 * | 2.48B | Sales 2025 * | 2.65B | Capitalization | 6.94B |
---|---|---|---|---|---|
Net income 2024 * | 272M | Net income 2025 * | 407M | EV / Sales 2024 * | 2.42 x |
Net cash position 2024 * | 939M | Net cash position 2025 * | 1.44B | EV / Sales 2025 * | 2.07 x |
P/E ratio 2024 * |
29.2
x | P/E ratio 2025 * |
17.1
x | Employees | 5,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.18% |
Latest transcript on Globus Medical, Inc.
1 day | +0.04% | ||
1 week | -1.00% | ||
Current month | -4.42% | ||
1 month | +0.23% | ||
3 months | -6.08% | ||
6 months | +1.69% | ||
Current year | -3.79% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Scavilla
CEO | Chief Executive Officer | 59 | 15-05-03 |
David Davidar
FOU | Founder | 58 | 03-02-28 |
David Paul
FOU | Founder | 57 | 03-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Zarrilli
BRD | Director/Board Member | 62 | 19-04-30 |
Rob Douglas
BRD | Director/Board Member | 64 | 19-12-10 |
James Tobin
BRD | Director/Board Member | 79 | 15-08-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.01% | 2 M€ | +5.19% | ||
0.99% | 152 M€ | -1.74% | - | |
0.74% | 16 M€ | -7.93% | ||
0.44% | 8 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 51.25 | +1.79% | 967,602 |
24-04-19 | 50.35 | -0.79% | 1,059,314 |
24-04-18 | 50.75 | -0.88% | 969,555 |
24-04-17 | 51.2 | -1.14% | 1,160,564 |
24-04-16 | 51.79 | -0.06% | 1,091,496 |
Delayed Quote Nyse, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.79% | 6.94B | |
-2.25% | 186B | |
-1.32% | 107B | |
-3.92% | 67.57B | |
+7.99% | 50.7B | |
+15.74% | 47.2B | |
-0.45% | 39.72B | |
+10.81% | 27.48B | |
+2.34% | 25.65B | |
+13.37% | 24.97B |
- Stock Market
- Equities
- GMED Stock